156 related articles for article (PubMed ID: 19667625)
1. Small airway asthma therapy, challenges, and the future.
Casale TB
Postgrad Med; 2003 Feb; 113(2 Suppl):15-20. PubMed ID: 19667625
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic significance of distal airway inflammation in asthma.
Martin RJ
J Allergy Clin Immunol; 2002 Feb; 109(2 Suppl):S447-60. PubMed ID: 11842317
[TBL] [Abstract][Full Text] [Related]
3. Effective control of asthma with hydrofluoroalkane flunisolide delivered as an extrafine aerosol in asthma patients.
Corren J; Nelson H; Greos LS; Bensch G; Goldstein M; Wu J; Wang S; Newman K
Ann Allergy Asthma Immunol; 2001 Nov; 87(5):405-11. PubMed ID: 11730183
[TBL] [Abstract][Full Text] [Related]
4. Part III: Location of asthma inflammation and the distal airways: clinical implications.
Kraft M
Curr Med Res Opin; 2007 Sep; 23 Suppl 3():S21-7. PubMed ID: 17925065
[TBL] [Abstract][Full Text] [Related]
5. Single-dose study to compare the pharmacokinetics of HFA flunisolide and CFC flunisolide.
Nolting A; Sista S; Abramowitz W
J Pharm Sci; 2002 Feb; 91(2):424-32. PubMed ID: 11835202
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.
Corren J; Tashkin DP
Clin Ther; 2003 Mar; 25(3):776-98. PubMed ID: 12852702
[TBL] [Abstract][Full Text] [Related]
7. Deposition and pharmacokinetics of flunisolide delivered from pressurized inhalers containing non-CFC and CFC propellants.
Richards J; Hirst P; Pitcairn G; Mahashabde S; Abramowitz W; Nolting A; Newman SP
J Aerosol Med; 2001; 14(2):197-208. PubMed ID: 11681651
[TBL] [Abstract][Full Text] [Related]
8. Flunisolide for the treatment of asthma.
Melani AS
Expert Rev Clin Pharmacol; 2014 May; 7(3):251-8. PubMed ID: 24716719
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetic and pharmacodynamic comparison of hydrofluoroalkane and chlorofluorocarbon formulations of budesonide.
Clearie KL; Williamson PA; Meldrum K; Gillen M; Carlsson LG; Carlholm M; Ekelund J; Lipworth BJ
Br J Clin Pharmacol; 2011 Apr; 71(4):504-13. PubMed ID: 21395643
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic equivalence of inhaled beclomethasone dipropionate with CFC and non-CFC (HFA 134a) propellants both delivered via the Easibreathe inhaler for the treatment of paediatric asthma.
Farmer IS; Middle M; Savic J; Perri VL; Herdman MJ
Respir Med; 2000 Jan; 94(1):57-63. PubMed ID: 10714480
[TBL] [Abstract][Full Text] [Related]
11. Flunisolide HFA for the treatment of asthma: an old friend reformulated.
Shafazand S; Colice G
Expert Opin Pharmacother; 2004 May; 5(5):1163-73. PubMed ID: 15155115
[TBL] [Abstract][Full Text] [Related]
12. Flunisolide HFA.
Waugh J; Goa KL
Am J Respir Med; 2002; 1(5):369-72; discussion 373. PubMed ID: 14720039
[TBL] [Abstract][Full Text] [Related]
13. Hydrofluoroalkane-134A beclomethasone or chlorofluorocarbon fluticasone: effect on small airways in poorly controlled asthma.
Thongngarm T; Silkoff PE; Kossack WS; Nelson HS
J Asthma; 2005 May; 42(4):257-63. PubMed ID: 16032934
[TBL] [Abstract][Full Text] [Related]
14. A reappraisal of the clinical efficacy of nebulized flunisolide in pediatric asthma: the Italian experience.
Kantar A; Mroueh S; Fiocchi A
Allergy Asthma Proc; 2007; 28(6):671-87. PubMed ID: 17883883
[TBL] [Abstract][Full Text] [Related]
15. Targeting the small airways asthma phenotype: if we can reach it, should we treat it?
Lipworth B
Ann Allergy Asthma Immunol; 2013 Apr; 110(4):233-9. PubMed ID: 23535085
[TBL] [Abstract][Full Text] [Related]
16. Hydrofluoroalkane formulations of inhaled corticosteroids for the treatment of asthma.
Zeidler M; Corren J
Treat Respir Med; 2004; 3(1):35-44. PubMed ID: 15174892
[TBL] [Abstract][Full Text] [Related]
17. Targeting small airways in asthma: improvement in clinical benefit?
Ulrik CS; Lange P
Clin Respir J; 2011 Jul; 5(3):125-30. PubMed ID: 21106032
[TBL] [Abstract][Full Text] [Related]
18. Asthma control with extrafine-particle hydrofluoroalkane-beclometasone vs. large-particle chlorofluorocarbon-beclometasone: a real-world observational study.
Barnes N; Price D; Colice G; Chisholm A; Dorinsky P; Hillyer EV; Burden A; Lee AJ; Martin RJ; Roche N; von Ziegenweidt J; Israel E
Clin Exp Allergy; 2011 Nov; 41(11):1521-32. PubMed ID: 21752116
[TBL] [Abstract][Full Text] [Related]
19. Health-related quality of life in moderate asthma: 400 microg hydrofluoroalkane beclomethasone dipropionate vs 800 microg chlorofluorocarbon beclomethasone dipropionate. The Study Group.
Juniper EF; Buist AS
Chest; 1999 Nov; 116(5):1297-303. PubMed ID: 10559091
[TBL] [Abstract][Full Text] [Related]
20. Quantification of Aerosol Hydrofluoroalkane HFA-134a Elimination in the Exhaled Human Breath Following Inhaled Corticosteroids Administration.
Shin HW; Barletta B; Yoonessi L; Meinardi S; Leu SY; Radom-Aizik S; Randhawa I; Nussbaum E; Blake DR; Cooper DM
Clin Transl Sci; 2015 Oct; 8(5):445-50. PubMed ID: 26155923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
